First National Daily eMedical Newspaper of India
Nobody Reports News Better Than Us  
Editorial
We have improved our eMediNexus Platform with a far superior user experience.
Please click here to try it
Editor-in-Chief eMediNexus – Dr KK Aggarwal
 
13th October 2018

Revisiting dengue: Look for rise in hematocrit and not just falling platelets

Dr KK Aggarwal, Recipient of Padma Shri

Whenever dengue strikes, platelet counts along with shortage of platelets become the high point of discussion and panic sets in. Because it is presumed that platelet transfusion is the main treatment option for dengue. This is not so.

Platelet transfusions are not needed unless the platelet counts are less than 10,000 or there is active bleeding and thickening of blood.

Dengue causes low platelet count, but low platelet count by itself is never dangerous because patients with heart disease, diabetes are prescribed antiplatelets like aspirin, where they have a beneficial effect in preventing thrombotic complications. They are asked to report if they develop bleeding while on antiplatelets. Patients with idiopathic thrombocytopenic purpura (ITP) always have a low platelet count and they live a normal life on medication...read more

Top News

New WHO noise guidelines for Europe released

WHO European Region has launched new "Environmental Noise Guidelines for the European Region (2018)", which provide strong evidence that noise is one of the top environmental hazards to both physical and mental health and well-being in the European Region. The document identifies levels at which noise has significant health impacts and recommends actions to reduce ... read more

Morning Medtalks

Morning MEDtalks with Dr KK Aggarwal 13th October 2018

According to the National Institute on Drug Abuse, in response to a request for comment from the website Tonic: "A previous substance use disorder is a risk factor for future development of substance use disorder (SUD)," but "It is also possible that someone who once had an SUD but doesn’t currently have one has a balance of risk and protective genetic and environmental factors that could allow for alcohol consumption without developing an AUD (alcohol use disorder)."... read more

Practice Updates

A new DNA-based test to determine blood compatibility

The US Food and Drug Administration has approved ID CORE XT, a molecular-based assay used in blood transfusion medicine to help determine blood compatibility. The assay can be used to determine blood donor and patient non-ABO red blood cell (RBC) types. ID CORE XT is the ... read more


Ultrasound helps predict the success of AV fistulas in individual dialysis patients

Findings from the Hemodialysis Fistula Maturation Study published Oct. 11, 2018 in the Journal of the American Society of Nephrology (JASN), certain parameters measured by ultrasound helped predict the success of an arteriovenous (AV) fistula, the preferred type of hemodialysis ... read more


Study shows survival benefit of duvelisib in difficult-to-treat leukemia and lymphoma patients

For some patients with relapsed or treatment-resistant chronic lymphocytic leukemia and small lymphocytic lymphoma, the investigational oral medicine duvelisib may significantly improve disease outcomes, suggests phase III trial data published Oct. 4, 2018 in the journal Blood. Duvelisib extended the progression-free survival from a median of 9.9 months on ofatumumab to... read more


Rivaroxaban FDA approved to reduce MACE in CAD and PAD patients

The US FDA has approved rivaroxaban to reduce the risk of major cardiovascular (CV) events, such as CV death, myocardial infarction (MI) and stroke, in people with chronic coronary or .. read more


Increased risk of suicide with benzodiazepines in COPD patients with comorbid PTSD

Long-term use of benzodiazepines in patients with chronic obstructive pulmonary disease (COPD) with comorbid posttraumatic stress disorder (PTSD) more than doubled their risk of suicide, according to a study of 44,555 veterans who received medical care between 2010 and... read more

eMedi Humor
Medicolegal Corner
eMedi Quiz
a. With the nighttime formula
b. 1/2 hour after meals
c. On an empty stomach
d. With meals
Lifestyle Updates
 
Inspirational Story 1: The Cross Room
Inspirational Story 2: Benefits of Struggling
Navratri is a time to let go of all desires and adopt a healthier lifestyle
Undertake fasting during this period after considering your health and associated conditions such as diabetes
 
New Delhi, 12 October 2018: The Heart Care Foundation of India (HCFI) wishes all its readers a very happy navratri. In the Hindu tradition, the process of spiritual Yagna starts from the first day of Navratri on Amavasya and ends up on Diwali, again on Amavasya. The first 10 days involve intense spiritual practice and the rest 20 days entail receiving its benefits. It is imperative for those observing this yagna and a fast to ensure that they do so without harming their health.

The first nine days, called Navratri are devoted to a process of purification and detoxification of mind, body and soul. During this period a person is required to lead a Satwik spiritual life devoting first three days into activities, which reduces negativity in the mind and the body; the next three days he is supposed to indulge in positive behavior and happenings and in the last three days he is supposed to read and learn about spiritual positive things in life.

To Read More or Comment, Click Here